Gualberto Gussoni

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli, Cecilia Becattini, Guy Meyer et al. · New England Journal of Medicine · 2020 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini et al. · The Lancet Oncology · 2009 · 598 citations

Medicine, Oncology, Pharmacology +13

Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry

Gualberto Gussoni, Stefania Frasson, Micaela La Regina et al. · Thrombosis Research · 2012 · 212 citations

Medicine, Hematology, Oncology +14

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Giancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs et al. · Thrombosis and Haemostasis · 2018 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

Walter Ageno, Maria Cristina Vedovati, Ander Cohen et al. · Thrombosis and Haemostasis · 2020 · 101 citations

Medicine, Hematology, Pharmacotherapy +17